Jeremy Skillington, PhD, CEO of Poolbeg Pharma, discusses the continued expansion of the POLB 002 patent family following European Patent Office approval.
Jeremy Skillington, PhD, CEO of Poolbeg Pharma, discusses the continued expansion of the POLB 002 patent family following European Patent Office approval.